Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
7.47
+0.07 (0.88%)
At close: Dec 27, 2024, 4:00 PM
7.53
+0.07 (0.87%)
After-hours: Dec 27, 2024, 7:03 PM EST

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $2.38M in the quarter ending September 30, 2024, a decrease of -9.81%. This brings the company's revenue in the last twelve months to $78.62M, down -33.82% year-over-year. In the year 2023, Vir Biotechnology had annual revenue of $86.18M, down -94.67%.

Revenue (ttm)
$78.62M
Revenue Growth
-33.82%
P/S Ratio
12.88
Revenue / Employee
$133,932
Employees
587
Market Cap
1.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 2.95B
OPKO Health 711.41M
ANI Pharmaceuticals 555.46M
Avadel Pharmaceuticals 138.16M
Gyre Therapeutics 105.03M
Bicycle Therapeutics 36.90M
Revenue Rankings